Recent evidence suggests that pathological misregulation of the transforming growth factor-β (TGF-β) pathway could be implicated in the development of several major diseases, including myocardial infarction [9], fibrotic disease [10], and inflammation processes [4]. Here, TGFB1 is linked to myocardial infarction.